Central Illustration.
Prognostic Implications According to Phenotype of Residual Inflammatory Risk in PCI-Treated Patients
Residual inflammatory risk (RIR) was determined by serial measurements of high-sensitivity C-reactive protein (hsCRP) at on-admission and 1-month follow-up. Compared with American cohort (Mount Sinai Hospital registry), East Asian cohort (GNUH registry) had a lower prevalence of persistent high RIR (18.3% vs 36.5%). Compared with other RIR phenotypes, persistent high RIR phenotype showed higher risks of all-cause death and major bleeding in patients undergoing percutaneous coronary intervention (PCI). MACE = major adverse cardiovascular events.